Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Taddei

Showing results (1-10 of 291) with videos related to

Pageof 30
Sort By:
Current Medical Research and Opinion|May 19, 2015
RAS inhibitors' dose-dependent efficacy: myth or reality?Stefano Taddei
European Heart Journal|May 21, 2026
The QUADRO trial: a regulatory study with rigorous design and robust evidenceStefano Taddei
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 9, 2015
Combination therapy in hypertension: what are the best options according to clinical pharmacology principles and controlled clinical trial evidence?Stefano Taddei
British Journal of Pharmacology|July 6, 2005
Evolving the concept of regulation of vascular tone in humansStefano Taddei
Minerva Medica|January 23, 2020
ACE-inhibitor/calcium antagonist combination: is this the first-choice therapy in arterial hypertension?Stefano Taddei
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|August 8, 2012
Fixed-dose combination therapy in hypertension: prosStefano Taddei
Hypertension (Dallas, Tex. : 1979)|September 30, 2009
Exogenous ghrelin on nitric oxide-endothelin 1 imbalance in metabolic syndrome: can we kill 2 birds with 1 stone?Stefano Taddei, Agostino Virdis
Journal of Hypertension|August 27, 2002
Endothelial dysfunction in essential hypertension: clinical implicationsStefano Taddei, Antonio Salvetti
Giornale Italiano Di Cardiologia (2006)|February 3, 2025
[Combination therapy in arterial hypertension: how to personalize treatment]Alessandra Bacca, Stefano Taddei
Hypertension (Dallas, Tex. : 1979)|September 13, 2006
Phosphodiesterase 5 inhibition to treat essential hypertension: is this the beginning of the story?Stefano Taddei, Lorenzo Ghiadoni
Pageof 30

Showing results (1-10 of 291) with videos related to

Sort By:
Pageof 30
Current Medical Research and Opinion|May 19, 2015
RAS inhibitors' dose-dependent efficacy: myth or reality?Stefano Taddei
European Heart Journal|May 21, 2026
The QUADRO trial: a regulatory study with rigorous design and robust evidenceStefano Taddei
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 9, 2015
Combination therapy in hypertension: what are the best options according to clinical pharmacology principles and controlled clinical trial evidence?Stefano Taddei
British Journal of Pharmacology|July 6, 2005
Evolving the concept of regulation of vascular tone in humansStefano Taddei
Minerva Medica|January 23, 2020
ACE-inhibitor/calcium antagonist combination: is this the first-choice therapy in arterial hypertension?Stefano Taddei
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|August 8, 2012
Fixed-dose combination therapy in hypertension: prosStefano Taddei
Hypertension (Dallas, Tex. : 1979)|September 30, 2009
Exogenous ghrelin on nitric oxide-endothelin 1 imbalance in metabolic syndrome: can we kill 2 birds with 1 stone?Stefano Taddei, Agostino Virdis
Journal of Hypertension|August 27, 2002
Endothelial dysfunction in essential hypertension: clinical implicationsStefano Taddei, Antonio Salvetti
Giornale Italiano Di Cardiologia (2006)|February 3, 2025
[Combination therapy in arterial hypertension: how to personalize treatment]Alessandra Bacca, Stefano Taddei
Hypertension (Dallas, Tex. : 1979)|September 13, 2006
Phosphodiesterase 5 inhibition to treat essential hypertension: is this the beginning of the story?Stefano Taddei, Lorenzo Ghiadoni
Pageof 30